This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hirukawa, S. Articles by Hu, G.-f. Search for Related Content PubMed PubMed Citation Articles by Hirukawa, S. Articles by Hu, G.-f.

Neamine Inhibits Xenografic Human Tumor Growth and Angiogenesis in Athymic Mice

Authors' Affiliation: Department of Pathology, Harvard Medical School, Boston, Massachusetts

Requests for reprints: Guo-fu Hu, Department of Pathology, Harvard Medical School, 77 Avenue Louis Pasteur, MA 02115. Phone: 617-432-6582; Fax: 617-432-6580; E-mail: guofu_hu{at}hms.harvard.edu.

Purpose: We have previously shown that the aminoglycoside antibiotic neomycin blocks the nuclear translocation of angiogenin and inhibits its angiogenic activity. However, neomycin has not been considered as a favorable drug candidate for clinical development because of its known nephrotoxicity and ototoxicity. The aim of this study is to determine whether neamine, a nontoxic derivative of neomycin, possesses antitumor activity.

Experimental Design: The effect of neamine on the nuclear translocation of angiogenin was examined by means of immunofluorescence and Western blotting. The antitumor activity of neamine was determined with three different animal models.

Results: Neamine effectively blocked the nuclear translocation of angiogenin in endothelial cells and inhibited angiogenin-induced cell proliferation. It inhibited the establishment of human tumor xenografts in athymic mice in both ectopic and orthotopic tumor models. It also inhibited the progression of established human tumor transplants, whereas the structurally related antibiotic paromomycin had no effect. Immunohistochemical staining showed that both angiogenesis and cancer cell proliferation are inhibited by neamine.

Conclusion: These results suggest that the nontoxic aminoglycoside antibiotic neamine is an effective inhibitor of nuclear translocation of angiogenin and may serve as an inhibitor for angiogenin-induced angiogenesis and cancer progression.

This article has been cited by other articles:

				S. Ibaragi, N. Yoshioka, S. Li, M. G. Hu, S. Hirukawa, P. M. Sadow, and G.-f. Hu Neamine Inhibits Prostate Cancer Growth by Suppressing Angiogenin-Mediated rRNA Transcription Clin. Cancer Res., March 15, 2009; 15(6): 1981 - 1988. [Abstract] [Full Text] [PDF]

				R. N. Re and J. L. Cook The Basis of an Intracrine Pharmacology J. Clin. Pharmacol., March 1, 2008; 48(3): 344 - 350. [Abstract] [Full Text] [PDF]

				N. Yoshioka, L. Wang, K. Kishimoto, T. Tsuji, and G.-f. Hu A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation PNAS, September 26, 2006; 103(39): 14519 - 14524. [Abstract] [Full Text] [PDF]